CoMFA, synthesis, and pharmacological evaluation of (E)-3-(2-carboxy-2-arylvinyl)-4,6-dichloro-1H-indole-2-carboxylic acids: 3-[2-(3-aminophenyl)-2-carboxyvinyl]-4,6-dichloro-1H-indole-2-carboxylic acid, a potent selective glycine-site NMDA receptor antagonist. 2005

Bruce M Baron, and Robert J Cregge, and Robert A Farr, and Dirk Friedrich, and Raymond S Gross, and Boyd L Harrison, and David A Janowick, and Donald Matthews, and Timothy C McCloskey, and Scott Meikrantz, and Philip L Nyce, and Roy Vaz, and William A Metz
Department of Medicinal Chemistry, Aventis Pharmaceuticals, Route 202-206, Bridgewater, New Jersey 08807-0800, USA.

(E)-3-(2-Carboxy-2-phenylvinyl)-4,6-dichloro-1H-indole-2-carboxylic acid, 1, is a potent and selective antagonist of the glycine site of the N-methyl-d-aspartate (NMDA) receptor. Using 3D comparative molecular field analysis (CoMFA) to guide the synthetic effort, a series of aryl diacid analogues of 1 were synthesized to optimize in vivo potency, duration of action, and binding activity. It was found that the incorporation of a substituted aromatic with an electron withdrawing group or a heterocyclic group at the 2-position of the 3-propenyl moiety of 1 gave compounds with better affinity and potency in the murine stroke model. Ultimately this led to the discovery of 3-[2-(3-aminophenyl)-2-carboxyvinyl]-4,6-dichloro-1H-indole-2-carboxylic acid, 19, as a new potent selective glycine-site NMDA receptor antagonist.

UI MeSH Term Description Entries
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D008297 Male Males
D008811 Mice, Inbred DBA An inbred strain of mouse. Specific substrains are used in a variety of areas of BIOMEDICAL RESEARCH such as DBA/1J, which is used as a model for RHEUMATOID ARTHRITIS. Mice, DBA,Mouse, DBA,Mouse, Inbred DBA,DBA Mice,DBA Mice, Inbred,DBA Mouse,DBA Mouse, Inbred,Inbred DBA Mice,Inbred DBA Mouse
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D010648 Phenylacetates Derivatives of phenylacetic acid. Included under this heading are a variety of acid forms, salts, esters, and amides that contain the benzeneacetic acid structure. Note that this class of compounds should not be confused with derivatives of phenyl acetate, which contain the PHENOL ester of ACETIC ACID. Benzeneacetates,Benzeneacetic Acids,Phenylacetic Acids,Acids, Benzeneacetic,Acids, Phenylacetic
D011869 Radioligand Assay Quantitative determination of receptor (binding) proteins in body fluids or tissue using radioactively labeled binding reagents (e.g., antibodies, intracellular receptors, plasma binders). Protein-Binding Radioassay,Radioreceptor Assay,Assay, Radioligand,Assay, Radioreceptor,Assays, Radioligand,Assays, Radioreceptor,Protein Binding Radioassay,Protein-Binding Radioassays,Radioassay, Protein-Binding,Radioassays, Protein-Binding,Radioligand Assays,Radioreceptor Assays
D002264 Carboxylic Acids Organic compounds containing the carboxy group (-COOH). This group of compounds includes amino acids and fatty acids. Carboxylic acids can be saturated, unsaturated, or aromatic. Carboxylic Acid,Acid, Carboxylic,Acids, Carboxylic
D005998 Glycine A non-essential amino acid. It is found primarily in gelatin and silk fibroin and used therapeutically as a nutrient. It is also a fast inhibitory neurotransmitter. Aminoacetic Acid,Glycine, Monopotassium Salt,Glycine Carbonate (1:1), Monosodium Salt,Glycine Carbonate (2:1), Monolithium Salt,Glycine Carbonate (2:1), Monopotassium Salt,Glycine Carbonate (2:1), Monosodium Salt,Glycine Hydrochloride,Glycine Hydrochloride (2:1),Glycine Phosphate,Glycine Phosphate (1:1),Glycine Sulfate (3:1),Glycine, Calcium Salt,Glycine, Calcium Salt (2:1),Glycine, Cobalt Salt,Glycine, Copper Salt,Glycine, Monoammonium Salt,Glycine, Monosodium Salt,Glycine, Sodium Hydrogen Carbonate,Acid, Aminoacetic,Calcium Salt Glycine,Cobalt Salt Glycine,Copper Salt Glycine,Hydrochloride, Glycine,Monoammonium Salt Glycine,Monopotassium Salt Glycine,Monosodium Salt Glycine,Phosphate, Glycine,Salt Glycine, Monoammonium,Salt Glycine, Monopotassium,Salt Glycine, Monosodium
D006152 Cyclic GMP Guanosine cyclic 3',5'-(hydrogen phosphate). A guanine nucleotide containing one phosphate group which is esterified to the sugar moiety in both the 3'- and 5'-positions. It is a cellular regulatory agent and has been described as a second messenger. Its levels increase in response to a variety of hormones, including acetylcholine, insulin, and oxytocin and it has been found to activate specific protein kinases. (From Merck Index, 11th ed) Guanosine Cyclic 3',5'-Monophosphate,Guanosine Cyclic 3,5 Monophosphate,Guanosine Cyclic Monophosphate,Guanosine Cyclic-3',5'-Monophosphate,3',5'-Monophosphate, Guanosine Cyclic,Cyclic 3',5'-Monophosphate, Guanosine,Cyclic Monophosphate, Guanosine,Cyclic-3',5'-Monophosphate, Guanosine,GMP, Cyclic,Guanosine Cyclic 3',5' Monophosphate,Monophosphate, Guanosine Cyclic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Bruce M Baron, and Robert J Cregge, and Robert A Farr, and Dirk Friedrich, and Raymond S Gross, and Boyd L Harrison, and David A Janowick, and Donald Matthews, and Timothy C McCloskey, and Scott Meikrantz, and Philip L Nyce, and Roy Vaz, and William A Metz
April 2000, Archives of pharmacal research,
Bruce M Baron, and Robert J Cregge, and Robert A Farr, and Dirk Friedrich, and Raymond S Gross, and Boyd L Harrison, and David A Janowick, and Donald Matthews, and Timothy C McCloskey, and Scott Meikrantz, and Philip L Nyce, and Roy Vaz, and William A Metz
June 2003, Bioorganic & medicinal chemistry letters,
Bruce M Baron, and Robert J Cregge, and Robert A Farr, and Dirk Friedrich, and Raymond S Gross, and Boyd L Harrison, and David A Janowick, and Donald Matthews, and Timothy C McCloskey, and Scott Meikrantz, and Philip L Nyce, and Roy Vaz, and William A Metz
May 2001, The Journal of organic chemistry,
Bruce M Baron, and Robert J Cregge, and Robert A Farr, and Dirk Friedrich, and Raymond S Gross, and Boyd L Harrison, and David A Janowick, and Donald Matthews, and Timothy C McCloskey, and Scott Meikrantz, and Philip L Nyce, and Roy Vaz, and William A Metz
March 1989, Science (New York, N.Y.),
Bruce M Baron, and Robert J Cregge, and Robert A Farr, and Dirk Friedrich, and Raymond S Gross, and Boyd L Harrison, and David A Janowick, and Donald Matthews, and Timothy C McCloskey, and Scott Meikrantz, and Philip L Nyce, and Roy Vaz, and William A Metz
September 2010, ChemMedChem,
Bruce M Baron, and Robert J Cregge, and Robert A Farr, and Dirk Friedrich, and Raymond S Gross, and Boyd L Harrison, and David A Janowick, and Donald Matthews, and Timothy C McCloskey, and Scott Meikrantz, and Philip L Nyce, and Roy Vaz, and William A Metz
April 2014, ACS medicinal chemistry letters,
Bruce M Baron, and Robert J Cregge, and Robert A Farr, and Dirk Friedrich, and Raymond S Gross, and Boyd L Harrison, and David A Janowick, and Donald Matthews, and Timothy C McCloskey, and Scott Meikrantz, and Philip L Nyce, and Roy Vaz, and William A Metz
February 2003, Journal of medicinal chemistry,
Bruce M Baron, and Robert J Cregge, and Robert A Farr, and Dirk Friedrich, and Raymond S Gross, and Boyd L Harrison, and David A Janowick, and Donald Matthews, and Timothy C McCloskey, and Scott Meikrantz, and Philip L Nyce, and Roy Vaz, and William A Metz
February 2000, Archives of pharmacal research,
Bruce M Baron, and Robert J Cregge, and Robert A Farr, and Dirk Friedrich, and Raymond S Gross, and Boyd L Harrison, and David A Janowick, and Donald Matthews, and Timothy C McCloskey, and Scott Meikrantz, and Philip L Nyce, and Roy Vaz, and William A Metz
November 1990, Neuroscience letters,
Bruce M Baron, and Robert J Cregge, and Robert A Farr, and Dirk Friedrich, and Raymond S Gross, and Boyd L Harrison, and David A Janowick, and Donald Matthews, and Timothy C McCloskey, and Scott Meikrantz, and Philip L Nyce, and Roy Vaz, and William A Metz
January 2003, Journal of medicinal chemistry,
Copied contents to your clipboard!